CYYNF

Stock ticker: OTC

PRICE

CHANGE

CAPITALIZATION

Cynata Therapeutics (CYYNF) Ownership - Who owns Cynata Therapeutics?

Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

100 Cubitt Street

Phone

+61 370676940

Employees

Web

https://www.cynata.com

Details

Group

Domestic Stock Funds

Fundamentals

CYYNF

Capitalization

26.2M

P/E Ratio

N/A

Risk (Beta)

-0.11

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

N/A

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

4.53

Cash Flow

N/A

Earnings

-0.05

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

-10.8M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-67.30

Shares Held By Institutions

2.52M

Shares Outstanding - Current

226M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

-27.895

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology